Jazz Pharmaceuticals
JAZZ
JAZZ
306 hedge funds and large institutions have $7.59B invested in Jazz Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 55 funds opening new positions, 88 increasing their positions, 122 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
306
Holders Change
+12
Holders Change %
+4.08%
% of All Funds
7.63%
Holding in Top 10
11
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+22.22%
% of All Funds
0.27%
New
55
Increased
88
Reduced
122
Closed
34
Calls
$111M
Puts
$57.1M
Net Calls
+$53.8M
Net Calls Change
+$77.8M
Top Buyers
| 1 |
BlackRock
New York
|
+$452M |
| 2 |
SIG
Senator Investment Group
New York
|
+$109M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$72.6M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$72M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$68.1M |
Top Sellers
| 1 |
TCP
Tourbillon Capital Partners
New York
|
-$92.1M |
| 2 |
Prudential Financial
Newark,
New Jersey
|
-$60.4M |
| 3 |
Renaissance Technologies
New York
|
-$58M |
| 4 |
CCM
Cadian Capital Management
New York
|
-$46.7M |
| 5 |
Two Sigma Investments
New York
|
-$39.3M |
